Datasetspublic full text
ClinicalTrials.gov
clinicaltrials · Datasets · License: Public Domain
186,442Documents
1,450Full text
2026-10-02Last indexed
Recent documents from this source
- Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism#28451
- Intravenous Labetalol vs Phentolamine for the Management of Severe Preeclampsia.#28450
- Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for Hypertension#28449
- Effects of Spironolactone in Dialysis#28448
- Predictors of Pulmonary Hypertension in Patients With Advanced Lung Diseases#28447
- Clinical and Biological Sample Database of Chinese Elderly Patients With Multiple Diseases#28446
- Clinical Trial on the Accuracy of Blood Pressure Measurement by YE990 Medical Automatic Electronic Sphygmomanometer#28445
- Effectiveness of Covid-19 Vaccination in Eswatini Against SARS-CoV-2 Associated Hospitalization and Death#28444
- Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma#28443
- 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Pneumococcal Vaccine-Naïve Adults 60 Years of Age and Older in Japan, Korea, and Taiwan#28442
- ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM#28441
- Immunogenicity of an Inactivated COVID-19 Vaccine#28440
- A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years#28439
- Typhoid Conjugate Vaccine Trial Among Children Younger Than 2 Years in Ouagadougou, Burkina Faso#28438
- Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell)#28437
- Randomized, Double Blind, Placebo-controlled Topical Resiquimod Adjuvant for NY-ESO-1 Protein Vaccination#28436
- Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer#28435
- Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older#28434
- A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults#28433
- A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.#28432
Source record · clinicaltrials · Datasets · License: Public Domain
Conceptio Open Knowledge Archive — counts are materialised per sync from the index (real full-text coverage, never license entitlement).